ESMO 2019: ADAPTeR study to evaluate the role of nivolumab before and after surgery – results of biomarker analysis
Results from the ADAPTeR study to evaluate the role of [...]
Results from the ADAPTeR study to evaluate the role of [...]
Results from a post-hoc analysis of JAVELIN-Renal 101 in patients [...]
A phase 2 study published in the British Journal of [...]
The following interviews with kidney cancer experts discuss the latest [...]
The European Association of Urology (EAU) held its annual congress [...]
A recent phase II study of 18 patients with clear-cell renal [...]
The following articles from various urology conferences in 2018 summarise [...]
The following articles discuss the use of neoadjuvant therapy (drug [...]
In this interview, Dr Daniel George from the Duke Cancer [...]
A comprehensive review of neoadjuvant therapy and adjuvant therapy for [...]